{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:44:44Z","timestamp":1791143084788,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.yexmp.2011.09.019","type":"journal-article","created":{"date-parts":[[2011,10,16]],"date-time":"2011-10-16T04:22:41Z","timestamp":1318738961000},"page":"20-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["MGMT and PTEN as potential prognostic markers in breast cancer"],"prefix":"10.1016","volume":"92","author":[{"given":"Julio Cirullo","family":"Neto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana Mari","family":"Ikoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia C\u00e2ndido","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Vassallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"De Brot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helenice","family":"Gobbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Augusto","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael Malagoli","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexmp.2011.09.019_bb0140","first-page":"155","article-title":"Prognostic and predictive factors in breast cancer by immunohistochemical analysis","volume":"11","author":"Allred","year":"1998","journal-title":"Modern Pathology"},{"key":"10.1016\/j.yexmp.2011.09.019_bb0125","first-page":"6941","article-title":"Lack of the DNA repair proteins O6-methylguanine-DNA methyltransferase in histologically normal brain adjacent to primary human brain tumors","volume":"93","author":"Bobola","year":"1996","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.yexmp.2011.09.019_bb0025","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/(SICI)1098-2744(199902)24:2<85::AID-MC2>3.0.CO;2-C","article-title":"Methylation of selected CpGs in the human O6-methylguanine-DNA methyltransferase promoter region as a marker of gene silencing","volume":"24","author":"Danam","year":"1999","journal-title":"Molecular Carcinogenesis"},{"key":"10.1016\/j.yexmp.2011.09.019_bb0055","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/modpathol.3880371","article-title":"Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer","volume":"14","author":"Depowski","year":"2001","journal-title":"Modern Pathology"},{"key":"10.1016\/j.yexmp.2011.09.019_bb0080","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nrc1319","article-title":"MGMT: its role in cancer aetiology and cancer therapeutics","volume":"4","author":"Gerson","year":"2004","journal-title":"Nature Reviews. Cancer"},{"key":"10.1016\/j.yexmp.2011.09.019_bb0110","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrc2342","article-title":"DNA repair pathways as targets for cancer therapy","volume":"8","author":"Helleday","year":"2008","journal-title":"Nature Reviews. Cancer"},{"key":"10.1016\/j.yexmp.2011.09.019_bb0005","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.dnarep.2007.03.013","article-title":"MGMT hypermethylation: a prognostic foe, a predictive friend","volume":"6","author":"Jacinto","year":"2007","journal-title":"DNA Repair"},{"key":"10.1016\/j.yexmp.2011.09.019_bb0090","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.dnarep.2007.03.008","article-title":"MGMT: key note in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents","volume":"6","author":"Kaina","year":"2007","journal-title":"DNA Repair"},{"key":"10.1016\/j.yexmp.2011.09.019_bb0150","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1158\/1078-0432.CCR-05-2543","article-title":"Targeted modulation of MGMT. clinical implications","volume":"12","author":"Liu","year":"2006","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.yexmp.2011.09.019_bb0035","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s10434-001-0807-9","article-title":"Expression and prognostic significance of O6-methylguanine-DNA methyltransferase in hepatocellular, gastric, and breast cancers","volume":"8","author":"Matsukura","year":"2001","journal-title":"Annals of Surgical Oncology"},{"key":"10.1016\/j.yexmp.2011.09.019_bb0065","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10549-007-9632-6","article-title":"Epidemiology of basal-like breast cancer","volume":"109","author":"Millikan","year":"2008","journal-title":"Breast Cancer Research and Treatment"},{"key":"10.1016\/j.yexmp.2011.09.019_bb0020","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.humpath.2006.04.013","article-title":"Pattern of expression of genes linked to epigenetic silencing in human breast cancer","volume":"37","author":"Munot","year":"2006","journal-title":"Human Pathology"},{"key":"10.1016\/j.yexmp.2011.09.019_bb0030","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/jjco\/hyi036","article-title":"Inverse correlation between the expression of O6-methylguanine-DNA methyl transferase (MGMT) and p53 in breast cancer","volume":"35","author":"Osanai","year":"2005","journal-title":"Japanese Journal of Clinical Oncology"},{"key":"10.1016\/j.yexmp.2011.09.019_bb0015","first-page":"6119","article-title":"Mammalian O6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents","volume":"50","author":"Pegg","year":"1990","journal-title":"Cancer Research"},{"key":"10.1016\/j.yexmp.2011.09.019_bb0010","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0079-6603(08)60879-X","article-title":"Structure, function, and inhibition of O6-alkylguanine-DNA alkyltransferase","volume":"51","author":"Pegg","year":"1995","journal-title":"Progress in Nucleic Acid Research and Molecular Biology"},{"key":"10.1016\/j.yexmp.2011.09.019_bb0105","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.dnarep.2007.03.012","article-title":"Human variants of O6-alkylguanine-DNA alkyltransferase","volume":"6","author":"Pegg","year":"2007","journal-title":"DNA Repair"},{"key":"10.1016\/j.yexmp.2011.09.019_bb0040","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/sj.bjc.6600126","article-title":"Activation of AKT\/PKB in breast cancer predicts a worse outcome among endocrine treated patients","volume":"86","author":"Perez-Tenorio","year":"2002","journal-title":"British Journal of Cancer"},{"key":"10.1016\/j.yexmp.2011.09.019_bb0060","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.yexmp.2011.09.019_bb0115","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0163-7258(97)00003-X","article-title":"Understanding and manipulating O6-methylguanine-DNA methyltransferase expression","volume":"74","author":"Pieper","year":"1997","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.yexmp.2011.09.019_bb0085","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.coph.2006.03.011","article-title":"Exploiting the role of o6-methylguanine-DNA-methyltransferase (MGMT) in cancer therapy","volume":"6","author":"Sabharwal","year":"2006","journal-title":"Current Opinion in Pharmacology"},{"key":"10.1016\/j.yexmp.2011.09.019_bb0135","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cell.2008.04.013","article-title":"Tenets of PTEN tumor suppression","volume":"133","author":"Salmena","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.yexmp.2011.09.019_bb0130","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.oraloncology.2006.05.007","article-title":"MGMT expression in oral precancerous and cancerous lesions: correlation with progression, nodal metastasis and poor prognosis","volume":"43","author":"Sawhney","year":"2007","journal-title":"Oral Oncology"},{"key":"10.1016\/j.yexmp.2011.09.019_bb0120","first-page":"3759","article-title":"Role of MGMT in tumor development, progression, diagnosis, treatment and prognosis","volume":"29","author":"Sharma","year":"2009","journal-title":"Anticancer Research"},{"key":"10.1016\/j.yexmp.2011.09.019_bb0075","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cell.2006.11.042","article-title":"Essential role for nuclear PTEN in maintaining chromosomal integrity","volume":"128","author":"Shen","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.yexmp.2011.09.019_bb0045","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/modpathol.3800296","article-title":"Reduced PTEN expression predicts relapse in patients with breast carcinoma treated by tamoxifen","volume":"18","author":"Shoman","year":"2004","journal-title":"Modern Pathology"},{"key":"10.1016\/j.yexmp.2011.09.019_bb0100","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1139\/o05-140","article-title":"Epigenetic silencing of the MGMT gene in cancer","volume":"83","author":"Soejima","year":"2005","journal-title":"Biochemistry and Cell Biology"},{"key":"10.1016\/j.yexmp.2011.09.019_bb0070","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","volume":"98","author":"Sorlie","year":"2001","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.yexmp.2011.09.019_bb0050","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1159\/000086981","article-title":"Reduced expression of PTEN protein and its prognostic implications in invasive ductal carcinoma of the breast","volume":"68","author":"Tsutsui","year":"2005","journal-title":"Oncology"},{"key":"10.1016\/j.yexmp.2011.09.019_bb0145","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1200\/JCO.2006.09.2775","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer","volume":"25","author":"Wolff","year":"2007","journal-title":"Journal of Clinical Oncology"}],"updated-by":[{"DOI":"10.1016\/j.yexmp.2014.01.006","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000}}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480011001614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480011001614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T02:35:45Z","timestamp":1757990145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480011001614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0014480011001614"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2011.09.019","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.yexmp.2014.01.006","asserted-by":"object"}]},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MGMT and PTEN as potential prognostic markers in breast cancer","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2011.09.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}